“Chimeric antigen receptor (CAR) T-cell therapy in multiple myeloma: The evolving Canadian landscape”, Can Hematol Today, vol. 2, no. 3, pp. 33–38, Nov. 2023, doi: 10.58931/cht.2023.2342.